DCF — SOUTHERN HILLS MEDICAL CENTER
Enterprise Value: $92.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$92.6M
Enterprise Value
$23.6M
PV of Cash Flows
$69.0M
PV of Terminal Value
$111.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $149.6M | $12.7M | 9.0% | $4.1M | $3.8M |
| Year 2 | $154.1M | $14.6M | 10.0% | $5.4M | $4.5M |
| Year 3 | $158.7M | $16.7M | 11.0% | $6.8M | $5.1M |
| Year 4 | $163.5M | $18.0M | 11.0% | $7.6M | $5.2M |
| Year 5 | $168.4M | $18.9M | 11.0% | $8.1M | $5.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $92.6M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$145.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000082626996
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5